Hints and tips:
Related Special Reports
...Alex Barker is the FT’s global media editor....
...“There’s nothing to lose with boosters,” said Burioni at the Vita-Salute San Raffaele University....
...to do, Barker points out....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...Chief executives rarely consume alcohol at lunch these days, especially pharmaceutical ones. But Albert Bourla has never really fitted the mould of the typical corporate boss....
...“Africa is a key market for Sputnik V,” said the Russian Direct Investment Fund, a Kremlin-run wealth fund overseeing Sputnik V’s foreign sales....
...Their pipeline is dependent on it,” said Adam Barker, healthcare equity analyst at Shore Capital. In contrast: “AstraZeneca is not a vaccine player at all....
...It’s the most accessible of all the vaccines and so will still be used widely if approved,” said Shore Capital’s Adam Barker....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...If there is a sense from this earnings season that confidence in a V-shaped recovery for profits is misplaced, then the impact will probably be hardest on companies with weak balance sheets, and on those...
...Alex Barker in London 19....
...Beyond these three biotechs, Crispr could end up transforming the entire pharmaceutical industry....
...Their concentrated ownership of industries such as airlines and pharmaceuticals may push up travel and drug prices, some academics argue....
...She worked as a janitorial supervisor at C&W client Lonza, a Swiss pharmaceuticals group, which has a production facility in Portsmouth, New Hampshire....
...He places human embryonic and pluripotent stem cells — that have the potential to grow into nearly every cell of the body — in tiny ‘U’ or ‘V’ shaped dishes in the lab to grow them into different types of...
...Pharmaceutical groups, which might see similar benefits from quantum technology in the long term, are still on the sidelines....
...Thanks to a series of court rulings since the mid-2000s, such as eBay v MercExchange in 2007, Mayo Collaborative Services v Prometheus Laboratories in 2012 and Alice Corp v CLS Bank in 2014, and the subsequent...
...Mitsuo Sawai, president of Sawai Pharmaceutical, is one such chief executive....
...the neuroscience business should not “shock investors but is likely to raise a debate over possible use of proceeds should any cash be generated and management of any earnings dilution [ie deleveraging v...
...(BBC, PNAS) La bella vita Italians are the world’s healthiest people, according to data that take in life expectancy, causes of death and risks ranging from blood pressure to smoking to malnutrition and...
...(FT) Taking care of business If you want something done ask a busy person, goes the adage, and research suggests that this might well be true, writes Emma De Vita....
...Mike Lynch OBE Invoke Capital Mike MacCana Founder, CertSimple Mike Tomkins Co-Founder, TopCashback Neville Crawley CEO, Quid Inc Niall Wass Entrepreneur in Residence, Atomico; and formerly...
...Aberdeen Asset Management and Canada Pension Plan have also voiced opposition to the deal, as has the local company Ilsung Pharmaceuticals, which holds 2 per cent....
...Irish pharmaceutical companies have also been able to make use of tax havens like Bermuda to achieve very low tax rates....
International Edition